tradingkey.logo
tradingkey.logo
Search

Dogwood Therapeutics Inc

DWTX
Add to Watchlist
1.640USD
+0.060+3.80%
Close 07-31 16:00ETQuotes delayed by 15 min
54.78MMarket Cap
LossP/E TTM

Shareholding Stats

Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
CK Life Sciences International Holdings, Inc.
73.84%
Armistice Capital LLC
10.63%
Vanguard Capital Management, LLC
0.40%
Orca Capital GmbH
0.21%
Vanguard Fiduciary Trust Co
0.19%
Other
14.73%
Shareholders
Shareholders
Proportion
CK Life Sciences International Holdings, Inc.
73.84%
Armistice Capital LLC
10.63%
Vanguard Capital Management, LLC
0.40%
Orca Capital GmbH
0.21%
Vanguard Fiduciary Trust Co
0.19%
Other
14.73%
Shareholder Types
Shareholders
Proportion
Corporation
73.84%
Hedge Fund
10.63%
Investment Advisor
0.81%
Investment Advisor/Hedge Fund
0.09%
Research Firm
0.03%
Other
14.59%

Institutional Shareholding

Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
40
3.70M
11.07%
+3.62M
2025Q4
39
108.81K
4.95%
--
2025Q3
40
108.81K
5.96%
-4.30K
2025Q2
39
113.11K
5.28%
-38.77K
2025Q1
44
151.88K
3.29%
+89.03K
2024Q4
46
30.86K
5.46%
-11.80K
2024Q3
47
70.56K
12.43%
+3.12K
2024Q2
50
67.43K
14.68%
+12.42K
2024Q1
48
55.11K
21.02%
-106.80K
2023Q4
46
62.40K
20.78%
+1.23K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
CK Life Sciences International Holdings, Inc.
24.66M
73.84%
+24.45M
+11568.38%
Nov 25, 2025
Armistice Capital LLC
3.55M
10.63%
+3.55M
--
Feb 10, 2026
Orca Capital GmbH
69.82K
0.21%
+69.82K
--
Mar 14, 2025
Geode Capital Management, L.L.C.
16.78K
0.05%
+1.70K
+11.24%
Dec 31, 2025
Marshall Wace LLP
11.65K
0.03%
+11.65K
--
Dec 31, 2025
BofA Global Research (US)
9.41K
0.03%
+9.40K
+58743.75%
Dec 31, 2025
UBS Financial Services, Inc.
1.75K
0.01%
+1.75K
--
Dec 31, 2025
Duncan (Gregory Scott)
2.30K
0.01%
--
--
Feb 10, 2026
View more
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.